✨ Free AI Report
Galderma Group AG: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Galderma Group AG
Company Research

Galderma Group AG: Business Overview, Financials & Competitive Analysis

Galderma S.A. is a Swiss pharmaceutical company based in Zug that specializes in dermatological treatments and skin care products. It was acquired by a consortium of private institutional investors in 2019 and remaine...

Analyst-debate audio for Galderma Group AG

AskCyborg analysts argue the bull and bear cases for Galderma Group AG across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
7/ 10Strong

Cyborg Score thesis

Specialized pure-play dermatology leader with diversified portfolio across aesthetics and therapeutics positioned in fast-growing...

Read the full analyst-debate transcript →
Industry Pharmaceuticals
4 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Galderma Group AG Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Galderma Group AG Overview

Pro stress-test →

Galderma S.A. is a Swiss pharmaceutical company based in Zug that specializes in dermatological treatments and skin care products. It was acquired by a consortium of private institutional investors in 2019 and remained under their ownership until its initial public offering in 2024. The company is the pure-play dermatology category leader present in approximately 90 countries, delivering an innovative, science-based portfolio of premium flagship brands spanning Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology.

Strategic Profile

Pro stress-test →

Galderma diversified into aesthetic medicine products with the botulinum toxin Azzalure, strengthening the field in 2010 with the acquisition of Swedish medical device company Q-Med. Main brands include Restylane, Azzalure, Dysport, Alluzience, Sculptra and Relfydess. The company operates three core business units focused on comprehensive dermatology solutions.

Competitive Landscape

Pro stress-test →

Galderma competes in the global dermatology market against diversified pharmaceutical companies and specialty aesthetic providers. Key competitors include AbbVie (Allergan, maker of Botox), Evolus (Jeuveau), Revance Therapeutics, and other dermatology-focused pharmaceutical firms. Galderma's advantage lies in its pure-play focus and integrated portfolio spanning multiple dermatology segments.

Industry Context

Galderma Group AG operates in Pharmaceuticals.

Key facts

Founded: 1981 · Headquarters: Zug, Switzerland · Employees: 4,600+ · Market cap: $34.79B CHF

What the analysts stress-tested

The top findings that survived the multi-agent debate for Galderma Group AG.

  • Recent IPO in 2024 provides capital for growth initiatives after private equity ownership since 2019
  • Three-pillar business model balances high-margin aesthetics with therapeutic dermatology and consumer skincare
+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 2026New CFO Luigi La Corte appointed effective May 1, 2026, bringing pharma and finance expertise
  • April 2025First Annual General Meeting held; approved 0.15 CHF dividend per share from capital reserves
  • +1 moreTrack every material event for Galderma Group AG as it happens. Explore monitoring →
Get alerted when Galderma Group AG has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

BotoxBotulinum toxin injectable for aesthetics and therapeutics→JeuveauBotulinum toxin aesthetic injectable→RHAHyaluronic acid dermal fillers and aesthetic treatments→KybellaDeoxycholic acid injectable for submental fullness→

Compare Galderma Group AG with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Galderma Group AG operates in Pharmaceuticals. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceuticals research →
NEW · MCP server

Ask your AI assistant about Galderma Group AG

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Galderma Group AG and its top competitor on Cyborg Score”
“What did Galderma Group AG do this quarter?”
“Is Galderma Group AG a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Galderma Group AG do?+
Galderma S.A. is a Swiss pharmaceutical company based in Zug that specializes in dermatological treatments and skin care products. It was acquired by a consortium of private institutional investors in 2019 and remaine...
What is Galderma Group AG's Cyborg Score?+
Galderma Group AG has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Galderma Group AG's main competitors?+
Named competitors include Botox, Jeuveau, RHA, Kybella. The full competitive landscape is in the AskCyborg report.
How can I get the full Galderma Group AG research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Galderma Group AG research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Galderma Group AG over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Pharmaceuticals research

Companies in the same sector and named competitors, ranked by Cyborg Score.

7Novartis AG7Recordati Industria Chimica e Farmaceutica SpA6CSPC Innovation Pharmaceutical Co., Ltd.